Beijing National Engineering Research Center for Biochips settled in Yantai

On December 2nd, the opening ceremony of the Yantai Branch Center of the Beijing National Engineering Research Center for Biochips was held in Yantai Yuhuangding Hospital. The deputy director of the Biochip Beijing National Research Center and the vice president of technology of Boao Biotechnology Co., Ltd. Xing Xiaoli unveiled the plaque jointly with Party Secretary and Dean of Yunding Hospital Liu Yunxiang.

The Beijing National Engineering Research Center for Biochips was established on September 30th, 2000. It was approved by the National Development and Reform Commission. It is based on Biotechnology's China Biochips, which has the largest product and market sales scale, the strongest R&D strength, and applications. The state-level research and development institution that has obtained the most patents. Biochip Beijing National Engineering Research Center Yantai Sub-center Relying on bio-chip technology, it is the first biochip research and development center in East China and one of the six sub-centers in China. According to Sun Chengming, deputy director of the biochip lab at the Yantai Subcentre, the biochip technology has the characteristics of high throughput, rapidity, and high sensitivity. It is mainly used in genetic diseases, infectious diseases, oncological diseases, genetic and related cardiovascular and cerebrovascular diseases, etc. The field is a new technology that cannot be replaced by other technologies at present. It can predict and detect diseases with the fastest speed. In 2005, the biochip of the SARS virus was developed successfully and can be screened at the same time for multiple people at the same time. The three major characteristics of biochip technology were confirmed.

After the inauguration ceremony, Vice President Xing Yuli gave a more detailed explanation of the biochip. "Commonly speaking, the chip of the biochip is a computerized representation of a computer technology that is more visualized. The biochip technology selects human secretions or blood based on the type of disease detection, and extracts genetic material nucleic acids from the blood for detection. Good prediction, diagnosis and treatment of some diseases.” Xing Xiaoli introduced that biochip technology has been applied to the field of disease detection, environmental testing, judicial testing and agricultural testing and other fields. At present, Yuding Hospital has introduced an individualized genetic testing chip, namely the “Love Profile” individual genetic test, which can comprehensively predict cardiovascular and cerebrovascular diseases, immune metabolic diseases, oncological diseases, mental and psychological diseases, hematological diseases, diabetes, liver diseases, and kidneys. Diseases and susceptibility measures the risk of nine major categories of 68 diseases, so as to achieve early prevention, early detection, early treatment, prevent or delay the occurrence of the disease. Xing Xiaoli pointed out that some genes are related to the detection of disease susceptibility, and further illustrated by the relationship between smoking and lung cancer: “Also is smoking, but some people who suffer from lung cancer do not have lung cancer, because they are susceptible to The genes of people who smoke in lung cancer have susceptibility to lung cancer, but they can be predicted in advance through individualized genetic test chip detection, thereby preventing them more effectively."

According to Xing Junli, the vice president, the total number of disabled people in the country totals more than 80 million, and about 20 million people are disabled because of deafness. Hereditary deafness is mainly due to parents having the same hereditary deafness gene, leading to deafness in children. If checking the spouse's inherited deafness gene before marriage or before pregnancy, re-election may prevent the fetus from inherited deafness; if you must be married to check during pregnancy and prenatal, you can determine whether the fetus is a genetic deafness; There is a situation where birth is normal but it is due to injections. This is mainly caused by parents who carry hereditary deafness gene and cause the child to be "homozygous". As long as aminoglycosides such as gentamicin and streptomycin are not used, It won't cause embarrassment, but many people don't know that all the tragedies have been made. Eighteen of the 21 deaf girls in "Avalokitesvara" are the victims of "a shot of suspicion." If they can pass the genetic biochip test, they can intervene early to avoid deafness.

The reporter learned that personalized genetic testing only needs to extract 1-2ml of blood and detect one or more diseases by extracting the nucleic acid of genetic material in the blood. Because the biochip has high-throughput characteristics, one person can complete multiple projects. Multiple human and multi-project inspections can be completed. After the test, a test report will be formed. The genetic counselor will make explanations and follow-up visits and other free follow-up services. Xing Xiaoli pointed out that although biochips are a "new creature" to most people, disease surveillance will become a trend in the future.